Skip to main content
. 2024 Nov 18;16(11):e73949. doi: 10.7759/cureus.73949

Table 4. Clinical outcomes between the beta-blocker and non-beta-blocker groups in patients with cardiovascular disease.

OR: odds ratio; CI: confidence interval

Outcome OR (95% CI)
Survival at 30 days
After multiple imputation and overlap weighting 1.04 (0.61-1.75)
Favorable neurological outcome at 30 days
After multiple imputation and overlap weighting 1.09 (0.61-1.93)